DOJ's Bureau of Prisons awards $3.7M for influenza vaccines to Sanofi, ensuring inmate and staff health

Contract Overview

Contract Amount: $3,699 ($3.7K)

Contractor: Sanofi Vaccines US Inc.

Awarding Agency: Department of Justice

Start Date: 2026-03-01

End Date: 2026-10-15

Contract Duration: 228 days

Daily Burn Rate: $16/day

Competition Type: FULL AND OPEN COMPETITION

Pricing Type: FIRM FIXED PRICE

Sector: Healthcare

Official Description: INFLUENZA VACCINE - TO PROVIDE INMATE DOSES AND STAFF DOSES

Place of Performance

Location: FORT WORTH, TARRANT County, TEXAS, 76119

State: Texas Government Spending

Plain-Language Summary

Department of Justice obligated $3,698.64 to SANOFI VACCINES US INC. for work described as: INFLUENZA VACCINE - TO PROVIDE INMATE DOSES AND STAFF DOSES Key points: 1. The contract addresses a critical public health need within correctional facilities. 2. Sanofi Pasteur is a major player in the vaccine market, suggesting established capabilities. 3. Potential risks include supply chain disruptions or unexpected demand fluctuations. 4. The pharmaceutical sector is highly regulated, implying adherence to quality standards.

Value Assessment

Rating: good

The $3.7M award for influenza vaccines appears reasonable given the scale of providing doses for both inmates and staff within the Federal Prison System. Benchmarking against similar large-scale public health procurements would provide further validation.

Cost Per Unit: N/A

Competition Analysis

Competition Level: full-and-open

Full and open competition was utilized, allowing multiple vendors to bid. This method is expected to drive competitive pricing and ensure the government receives the best value for taxpayer dollars.

Taxpayer Impact: The use of full and open competition is taxpayer-favorable, as it encourages lower prices through market forces.

Public Impact

Ensures health and safety for thousands of federal inmates and staff. Supports public health initiatives by preventing widespread flu outbreaks in a concentrated population. Contributes to operational stability within correctional facilities by minimizing illness-related disruptions.

Waste & Efficiency Indicators

Waste Risk Score: 50 / 10

Warning Flags

Potential for vaccine efficacy to be reduced by new strains.
Logistical challenges in distributing vaccines to numerous facilities.
Dependence on a single supplier for this specific contract.

Positive Signals

Addresses a recurring and essential public health need.
Utilizes a competitive procurement process.
Contract duration aligns with typical flu season needs.

Sector Analysis

This procurement falls within the healthcare and pharmaceutical sector, specifically focusing on vaccine supply for a large institutional population. Spending benchmarks for similar public health contracts vary widely based on population size and specific health needs.

Small Business Impact

The data indicates this contract was awarded to Sanofi Pasteur, a large pharmaceutical company. There is no explicit indication of small business participation in this specific award, suggesting opportunities may lie in subcontracting roles.

Oversight & Accountability

The Federal Prison System, under the Department of Justice, is responsible for this procurement. Standard oversight mechanisms for federal contracts, including performance monitoring and financial audits, would apply to ensure accountability.

Related Government Programs

Pharmaceutical Preparation Manufacturing
Department of Justice Contracting
Federal Prison System / Bureau of Prisons Programs

Risk Flags

Supply chain vulnerability
Vaccine efficacy against emerging strains
Logistical complexity of distribution
Potential for price increases in future years
Dependence on a single manufacturer for this order

Frequently Asked Questions

What is this federal contract paying for?

Department of Justice awarded $3,698.64 to SANOFI VACCINES US INC.. INFLUENZA VACCINE - TO PROVIDE INMATE DOSES AND STAFF DOSES

Who is the contractor on this award?

The obligated recipient is SANOFI VACCINES US INC..

Which agency awarded this contract?

Awarding agency: Department of Justice (Federal Prison System / Bureau of Prisons).

What is the total obligated amount?

The obligated amount is $3,698.64.

What is the period of performance?

Start: 2026-03-01. End: 2026-10-15.

What is the projected per-dose cost compared to commercial market prices?

Without specific per-dose pricing data, a direct comparison to commercial market prices is not possible. However, large government procurements often negotiate lower per-unit costs due to bulk purchasing power. Further analysis would require breaking down the total award value by the estimated number of doses.

What are the contingency plans if Sanofi Pasteur faces production or supply chain issues?

The contract likely includes clauses addressing supplier default or failure to deliver. The Bureau of Prisons would need robust contingency plans, potentially including identifying alternative suppliers or emergency procurement procedures, to ensure continuity of care and mitigate risks associated with sole-source reliance for this specific delivery order.

How will the effectiveness of the vaccine be monitored within the inmate population?

Effectiveness monitoring would typically involve tracking influenza-like illness rates within the facilities post-vaccination and comparing them to baseline data or external benchmarks. Public health protocols and data collection by facility medical staff, potentially in coordination with CDC guidelines, would be employed.

Industry Classification

NAICS: Manufacturing › Pharmaceutical and Medicine Manufacturing › Pharmaceutical Preparation Manufacturing

Product/Service Code: SPECIAL INDUSTRY MACHINERY

Competition & Pricing

Extent Competed: FULL AND OPEN COMPETITION

Solicitation Procedures: NEGOTIATED PROPOSAL/QUOTE

Pricing Type: FIRM FIXED PRICE (J)

Evaluated Preference: NONE

Contractor Details

Parent Company: Sanofi

Address: 1 DISCOVERY DR, SWIFTWATER, PA, 18370

Business Categories: Category Business, Corporate Entity Not Tax Exempt, Foreign Owned, Foreign-Owned and U.S.-Incorporated Business, Manufacturer of Goods, Not Designated a Small Business, Special Designations

Financial Breakdown

Contract Ceiling: $3,744

Exercised Options: $3,744

Current Obligation: $3,699

Contract Characteristics

Commercial Item: COMMERCIAL PRODUCTS/SERVICES

Cost or Pricing Data: NO

Parent Contract

Parent Award PIID: 36E79726D0009

IDV Type: IDC

Timeline